LGI1 Antibody, Cell-based IFA
What is the LGI1 Antibody Test?
The LGI1 Antibody, Cell-based IFA test is used to detect antibodies against the Leucine-Rich Glioma-Inactivated 1 (LGI1) protein. This test helps identify certain autoimmune neurological conditions, including a rare type of autoimmune encephalitis, which is a brain inflammation caused by the immune system mistakenly attacking healthy brain cells.
Why is this Test Important?
The presence of LGI1 antibodies in the blood can indicate LGI1 autoimmune encephalitis, a condition that can cause memory loss, confusion, seizures, and abnormal movements. This disorder is often not caused by an infection or cancer, but rather by the body’s immune system attacking its own brain tissue.
Early detection is critical. When caught early, many patients respond well to immune-modulating treatments, and symptoms can significantly improve or even fully resolve.
Conditions Linked to LGI1 Antibodies
-
Autoimmune limbic encephalitis (affecting memory and behavior)
-
Focal seizures, often involving facial or arm movements
-
Hyponatremia (low sodium levels in the blood), which can worsen confusion or fatigue
Unlike some other autoimmune brain conditions, LGI1 antibody-associated encephalitis is less commonly linked to cancer, making it a non-paraneoplastic form of encephalitis.
How is the Test Performed?
This test uses a cell-based indirect immunofluorescence assay (IFA) to detect LGI1 antibodies in a blood sample. The cell-based IFA method is highly specific and helps reduce the chance of false positives.
What Do the Results Mean?
-
Positive LGI1 antibodies suggest that your immune system is targeting the LGI1 protein, which may be causing neurological symptoms. This result supports a diagnosis of autoimmune encephalitis and may prompt treatment with immunotherapy.
-
Negative results mean LGI1 antibodies were not detected, but this does not fully rule out autoimmune brain conditions. Your doctor may order other tests if symptoms continue.
What Should I Do Next?
If your test is positive, your healthcare provider may recommend:
-
MRI or EEG to look for brain inflammation or abnormal electrical activity
-
Immunotherapy (like steroids or IVIG)
-
Follow-up with a neurologist who specializes in autoimmune or inflammatory brain diseases
Summary
The LGI1 Antibody, Cell-based IFA test plays a vital role in diagnosing a treatable form of autoimmune encephalitis. If you’re experiencing unexplained memory loss, seizures, or behavioral changes, this test can help uncover an immune-related cause—and guide you to the right treatment path.
LGI1 Antibody, Cell-based IFA
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.